Wellgen Medical Partners with Chulalongkorn University to Advance AI Imaging for Tuberculosis and Cancer Detection

A New Partnership — Bridging Taiwan and Thailand Through AI Innovation
Thanks to a connection facilitated by the NVIDIA Technology Office in Singapore, Wellgen Medical is honored to establish a formal collaborative relationship with the Faculty of Medicine, Chulalongkorn University, Thailand's most prestigious academic institution, for the co-development of AI imaging recognition algorithms.
Scope of Collaboration — Dual Focus on Tuberculosis and Cancer Detection
This collaborative effort targets two critical areas of clinical need: pulmonary smear images for tuberculosis screening, and cytology smear images for the detection of metastatic cancer, extending Wellgen's AI capabilities across infectious disease and oncology applications.
Industry Value — Open Collaboration for the Good of Mankind
Wellgen is especially encouraged that the academic and research experts at Chulalongkorn University embraced its vision of "open image" development, working together to advance AI algorithms that serve the greater good of mankind. This partnership reflects Wellgen's continued commitment to international collaboration and its core mission of "AI-Assisted Diagnosis," extending its reach into new academic and clinical communities across Asia.